These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6127066)

  • 41. Movement disorders with neuroleptic drug treatment.
    Tarsy D
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France.
    Bondon-Guitton E; Perez-Lloret S; Bagheri H; Brefel C; Rascol O; Montastruc JL
    Mov Disord; 2011 Oct; 26(12):2226-31. PubMed ID: 21674626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tardive parkinsonism in a bipolar patient: post-mortem examination supports a physiological rather than pathological dysfunction.
    Won MS; Mikos A; Hurd M; Fernandez H; Eskin T; Romrell J; Okun MS
    Neurocase; 2008; 15(1):66-9. PubMed ID: 19235627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Burns RS; LeWitt PA; Ebert MH; Pakkenberg H; Kopin IJ
    N Engl J Med; 1985 May; 312(22):1418-21. PubMed ID: 2581135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A longitudinal study of correlations among tardive dyskinesia, drug-induced parkinsonism, and psychosis.
    Hansen TE; Weigel RM; Brown WL; Hoffman WF; Casey DE
    J Neuropsychiatry Clin Neurosci; 1992; 4(1):29-35. PubMed ID: 1352714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Managing antipsychotic-induced parkinsonism.
    Mamo DC; Sweet RA; Keshavan MS
    Drug Saf; 1999 Mar; 20(3):269-75. PubMed ID: 10221855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.
    Hausner RS
    J Clin Psychiatry; 1983 Jan; 44(1):13-6. PubMed ID: 6130081
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
    Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
    Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroleptic malignant syndrome: a case report.
    Fekadu A; Wakwoya A
    Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HLA antigens in drug-induced parkinsonism.
    Metzer WS; Newton JE; Steele RW; Claybrook M; Paige SR; McMillan DE; Hays S
    Mov Disord; 1989; 4(2):121-8. PubMed ID: 2567491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extrapyramidal side effects in patients with Alzheimer's disease treated with low-dose neuroleptic medication.
    Caligiuri MP; Rockwell E; Jeste DV
    Am J Geriatr Psychiatry; 1998; 6(1):75-82. PubMed ID: 9469217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Neuroleptic parkinsonism].
    Izakson KhA
    Med Sestra; 1986 Sep; 45(9):50-2. PubMed ID: 2880275
    [No Abstract]   [Full Text] [Related]  

  • 53. The pharmacology of parkinsonism (a review).
    Klawans HL
    Dis Nerv Syst; 1968 Dec; 29(12):805-16. PubMed ID: 4388368
    [No Abstract]   [Full Text] [Related]  

  • 54. The diagnosis and treatment of neuroleptic-induced Parkinsonism.
    Hoffman BF
    Hosp Community Psychiatry; 1981 Feb; 32(2):110-4. PubMed ID: 6115811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Asymmetry in clinical features of drug-induced parkinsonism.
    Sethi KD; Zamrini EY
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):64-6. PubMed ID: 1983774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differentiating Parkinson's disease from drug-induced Parkinsonism.
    Wearne D; McCarthy M; Orr C
    Aust N Z J Psychiatry; 2019 Sep; 53(9):923-924. PubMed ID: 30897918
    [No Abstract]   [Full Text] [Related]  

  • 57. Using striatal dopamine transporter single photon emission computed tomography imaging to rule out Dementia with Lewy Bodies in elderly patients with antipsychotic-induced parkinsonism.
    Schuster JP; Buhl C; Archambaud F; Hardy P; Chouinard G; Prigent A; Corruble E
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):206. PubMed ID: 17362445
    [No Abstract]   [Full Text] [Related]  

  • 58. Drug-induced dysphagia.
    Bulling M
    Aust N Z J Med; 1999 Oct; 29(5):748. PubMed ID: 10630662
    [No Abstract]   [Full Text] [Related]  

  • 59. [Parkinsonism following addition of fluoxetine to the treatment with neuroleptics or carbamazepine].
    Touw DJ; Gernaat HB; van der Woude J
    Ned Tijdschr Geneeskd; 1992 Feb; 136(7):332-4. PubMed ID: 1347157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug-induced parkinsonism following chronic methamphetamine use by a patient on haloperidol decanoate.
    Matthew BJ; Gedzior JS
    Int J Psychiatry Med; 2015; 50(4):405-11. PubMed ID: 26526398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.